Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,965.87
(
-0.02%
)
News Focus
News Focus
Post# of 704041
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bethere

Send PM Follow Ignore
Followers 16
Posts 2100
Boards Moderated 0
Alias Born 10/04/2002

bethere

Re: Zeev Hed post# 135580

Wednesday, 07/30/2003 11:16:31 AM

Wednesday, July 30, 2003 11:16:31 AM

Post# of 704041
Firm reiterates its Underperform rating after Q2 results depict slowing sales of the co's most important drug, Copaxone for multiple sclerosis; notes that the deceleration comes despite the possibility that wholesalers stocked up on Copaxone in the quarter in advance of a price increase which could hurt Q3 sales.

Ô¿Ô GEEZ You Look Great!!!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today